This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Mar 22;378(12):1164.

doi: 10.1056/NEJMc1801663.

Adverse Events Associated with Immune Checkpoint Blockade

Bharat Kumar^{1

2}, Zuhair Ballas¹

Affiliations

PMID: 29565520
PMCID: PMC6433406
DOI: 10.1056/NEJMc1801663

Comment

Adverse Events Associated with Immune Checkpoint Blockade

Bharat Kumar et al. N Engl J Med. 2018.

. 2018 Mar 22;378(12):1164.

doi: 10.1056/NEJMc1801663.

Authors

Bharat Kumar^{1

2}, Zuhair Ballas¹

Affiliations

¹ University of Iowa Carver College of Medicine, Iowa City, IA
² bharat-kumar@uiowa.edu

PMID: 29565520
PMCID: PMC6433406
DOI: 10.1056/NEJMc1801663

No abstract available

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest relevant to this letter was reported.

Comment in

Adverse Events Associated with Immune Checkpoint Blockade.
Postow MA, Hellmann MD. Postow MA, et al. N Engl J Med. 2018 Mar 22;378(12):1165. doi: 10.1056/NEJMc1801663. N Engl J Med. 2018. PMID: 29562154 No abstract available.

Comment on

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.
Postow MA, Sidlow R, Hellmann MD. Postow MA, et al. N Engl J Med. 2018 Jan 11;378(2):158-168. doi: 10.1056/NEJMra1703481. N Engl J Med. 2018. PMID: 29320654 Review. No abstract available.

Similar articles

Adverse Events Associated with Immune Checkpoint Blockade.
Cohen Tervaert JW, Ye C, Yacyshyn E. Cohen Tervaert JW, et al. N Engl J Med. 2018 Mar 22;378(12):1164-5. doi: 10.1056/NEJMc1801663. N Engl J Med. 2018. PMID: 29565521 No abstract available.
Adverse Events Associated with Immune Checkpoint Blockade.
Postow MA, Hellmann MD. Postow MA, et al. N Engl J Med. 2018 Mar 22;378(12):1165. doi: 10.1056/NEJMc1801663. N Engl J Med. 2018. PMID: 29562154 No abstract available.
Adverse Events Associated with Immune Checkpoint Blockade.
Jhaveri KD, Perazella MA. Jhaveri KD, et al. N Engl J Med. 2018 Mar 22;378(12):1163. doi: 10.1056/NEJMc1801663. N Engl J Med. 2018. PMID: 29565518 No abstract available.
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.
Mahoney KM, Freeman GJ, McDermott DF. Mahoney KM, et al. Clin Ther. 2015 Apr 1;37(4):764-82. doi: 10.1016/j.clinthera.2015.02.018. Epub 2015 Mar 29. Clin Ther. 2015. PMID: 25823918 Free PMC article. Review.
Immune Checkpoint Blockade in Breast Cancer Therapy.
Bu X, Yao Y, Li X. Bu X, et al. Adv Exp Med Biol. 2017;1026:383-402. doi: 10.1007/978-981-10-6020-5_18. Adv Exp Med Biol. 2017. PMID: 29282694 Review.

See all similar articles

Cited by

Acute Non-infectious Cystitis Secondary to Immune-Related Adverse Events in a Patient Receiving Pembrolizumab for Treatment of Non-small Cell Lung Cancer: A Case Report.
Alhusari L, Abdallah M, Nwanwene K, Shenouda M. Alhusari L, et al. Cureus. 2024 Mar 6;16(3):e55666. doi: 10.7759/cureus.55666. eCollection 2024 Mar. Cureus. 2024. PMID: 38586668 Free PMC article.
Neurotoxicity and safety of the rechallenge of immune checkpoint inhibitors: a growing issue in neuro-oncology practice.
Villagrán-García M, Velasco R. Villagrán-García M, et al. Neurol Sci. 2022 Apr;43(4):2339-2361. doi: 10.1007/s10072-022-05920-4. Epub 2022 Feb 17. Neurol Sci. 2022. PMID: 35175441 Review.
Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events.
Poto R, Troiani T, Criscuolo G, Marone G, Ciardiello F, Tocchetti CG, Varricchi G. Poto R, et al. Front Immunol. 2022 Mar 30;13:804597. doi: 10.3389/fimmu.2022.804597. eCollection 2022. Front Immunol. 2022. PMID: 35432346 Free PMC article. Review.
Adverse events induced by immune checkpoint inhibitors.
Perdigoto AL, Kluger H, Herold KC. Perdigoto AL, et al. Curr Opin Immunol. 2021 Apr;69:29-38. doi: 10.1016/j.coi.2021.02.002. Epub 2021 Feb 25. Curr Opin Immunol. 2021. PMID: 33640598 Free PMC article. Review.
Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors.
Lee DJ, Lee HJ Jr, Farmer JR, Reynolds KL. Lee DJ, et al. Curr Cardiol Rep. 2021 Jul 1;23(8):98. doi: 10.1007/s11886-021-01530-2. Curr Cardiol Rep. 2021. PMID: 34196833 Review.

See all "Cited by" articles

References

1. Ceeraz S, Nowak EC, Burns CM, Noelle RJ. Immune checkpoint receptors in regulating immune reactivity in rheumatic disease. Arthritis Res Ther 2014; 16: 469. - PMC - PubMed
1. van der Vlist M, Kuball J, Radstake TR, Meyaard L. Immune checkpoints and rheumatic diseases: what can cancer immuno-therapy teach us? Nat Rev Rheumatol 2016; 12: 593–604. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations